CCS
MRK icon

Crosspoint Capital Strategies’s Merck MRK Stock Holding History

Crosspoint Capital Strategies’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-3,397
Closed -$180K – 551
2015
Q4 		$180K Buy
3,397
+461
+16% +$23.2K 0.05% 248
2015
Q3 		$138K Buy
2,936
+1,014
+53% +$53.9K 0.16% 135
2015
Q2 		$104K Sell
1,922
-349
-15% -$19.6K 0.03% 269
2015
Q1 		$125K Sell
2,271
-4,228
-65% -$239K 0.06% 177
2014
Q4 		$352K Buy
6,499
+3,050
+88% +$170K 0.12% 138
2014
Q3 		$195K Buy
3,449
+94
+3% +$5.28K 0.14% 105
2014
Q2 		$186K Sell
3,355
-3,167
-49% -$173K 0.07% 138
2014
Q1 		$353K Hold
6,522
– – 0.14% 98
2013
Q4 		$355K Buy
+6,522
New +$298K 0.12% 108

Other funds holding MRK

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Crosspoint Capital Strategies's MRK Position: Q1 2016 in Review

Crosspoint Capital Strategies sold out of Merck (MRK) in Q1 2016, closing a stake of 3,397 shares — an estimated $180K sold.

Crosspoint Capital Strategies first reported a position in MRK in Q4 2013 and held it in 9 quarters. The position peaked at $355K in Q4 2013. 1,744 funds tracked by Wall St. Rank hold MRK as of Q1 2016.

  • Crosspoint Capital Strategies reported no remaining Merck position as of Q1 2016 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 3,397 Merck shares in Q1 2016, an estimated $180K.
  • Crosspoint Capital Strategies first reported a position in Merck in Q4 2013 and held it in 9 quarters.
  • Crosspoint Capital Strategies's Merck position peaked at $355K in Q4 2013.
  • 1,744 funds tracked by Wall St. Rank held Merck as of Q1 2016.

Based on Crosspoint Capital Strategies's 13F filing for Q1 2016, filed 16 May 2016.